At first glance, it's a happy image: hundreds of smiling faces torn from newspapers and pasted into a frame. But these are ...

Turkey on Thursday commemorates the second anniversary of the February 6, 2023 earthquake, which claimed nearly 60,000 lives ...

For millions of Hindu pilgrims at India's millennia-old vast Kumbh Mela festival, the culmination of their journey is ritual ...

Growing up in the rugged northern reaches of Pakistan, Anita Karim honed her combat skills fighting with three older brothers ...

Asian markets rose Thursday, tracking gains on Wall Street and following the US Postal Service's U-turn on a ban on parcels ...

With his dizzying moves to slash spending, abolish government departments and lay off much of the federal workforce, Donald ...

In Morocco's tourist hub of Marrakesh, a contemporary art fair has energised the local creative scene, drawing on the famed ...

No team has ever won three of these games in a row. In fact, it’s exceedingly rare to advance far enough to even have the ...

Google parent company Alphabet has stopped making diversity and inclusion a workplace priority, according to a filing Wednesday with US regulators.

Imitation is the sincerest form of flattery, as the saying goes, and Argentina's President Javier Milei has made clear his ...

From injecting disinfectant to taking over Gaza, Donald Trump has long thrown outlandish suggestions at tough problems. But the question is always the same: is he serious?

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.